New Telegraph

FG Vows To Improve Research, Support Local Manufacturing Of Medicine, Vaccines

The Federal Government has vowed to improve and increase domestic research to support innovative local manufacturing of medicines and vaccines in Nigeria, as this would bring about equity and quality health services for all Nigerians.

The Special Adviser to the President on Health, Dr Salma Anas-Kolo, made this known at a webinar organized by the Director General of the National Institute for Pharmaceutical Research and Development (NIPRD), Dr Obi Adigwe, with the support of the European Union (EU) and the Bulgarian Government on Friday, with the theme “Expediting Local Vaccines Manufacturing in Nigeria: Challenges, Opportunities and Prospects.”

According to her, President Bola Ahmed Tinubu’s administration would ensure the validated and cost National Plan/Road Map for Vaccine Research and Development (R&D) and local production in Nigeria was given the needed political will for a successful implementation.

She said: “One of the pillars of Mr President in delivering Renewed Hope for Nigerians in the health sector, is improving and increasing domestic research to support innovative local manufacturing of Medicine, Technology and Vaccines to achieve equity and quality health services for all.

“The Federal government plan to work with the stakeholders, encourage and fund local research for new drugs, vaccines and disease epidemiology, determining best approaches to disease management within our local context.

“Federal Government is keen and interested in the outcome of this project, to ensure that the desired results of sustainable Vaccine Research and Development (R&D) and local production in Nigeria are achieved.”

She commended the European Union and the Bulgarian Government for their support of local production of vaccine readiness in Nigeria.

The Director General of NIPRD, Dr Obi Adigwe, said the need to build local vaccine capacity to address health issues in the country was proven right by the COVID-19 pandemic.

Adigwe who reiterated that they were huge opportunities for local vaccine manufacturing in the country added that “the development of a sustainable ecosystem in terms of research, business and policy-making will support the success of vibrant local manufacturing entities in Nigeria and across Africa.”

European Union Ambassador, H.E Samuella Isopi, said the EU was committed to the initiative of creating an enabling environment for local pharmaceutical manufacturing in Nigeria.

Represented by Professor Leila Ben Amor, she indicated that the collaboration between NIPRD, the EU and the Bulgarian Government seeks to complement the efforts of the Nigerian Government by bridging the gaps between research and industries in the pharmaceutical sector.

She, therefore, announced the G-20’s one billion Euros funding from the EU and the World Bank to support equitable access to effective quality, safe and affordable vaccines, medicines and health technologies in Africa.

On his part, the Bulgarian Ambassador to Nigeria, H.E Yanko Yordanov, indicated that the project provided an added value in terms of capacity building for Nigeria and other countries across Africa.

Read Previous

Int’l Widows Day: Plateau First Lady Pledge To Work, Support Widows

Read Next

Oyebanji To Forward Names Of Commissioners To Ekiti Assembly Next Week